Café-Au-Lait Macules in Neurofibromatosis Type 1: Birthmark or Biomarker?
Open Access
Abstract
Background: Neurofibromatosis type 1 (NF1) is a rare multisystem disorder characterized by variable expressivity and increased tumor risk. Café-au-lait macules (CALMs) are a hallmark of the disease, often representing one of the earliest clinical manifestations and allowing a clinical NF1 diagnosis if six or more are present. In this study, we aimed to investigate the prognostic value of CALMs at birth in NF1 patients. Methods: We conducted a retrospective study in patients aged ≥ 4 years presenting with CALMs at our Institution between 2020 and 2021, with a minimum follow-up of four years. We retrospectively collected data on CALMs at birth and other clinical manifestations associated with NF1. Results: Among 208 patients evaluated, including 147 with a confirmed diagnosis of NF1, 110 did not show CALMs at birth, and 98 had at least one. The absence of CALMs at birth did not correlate with a lower likelihood of NF1. In contrast, the CALM number at birth directly correlated with the likelihood of NF1, up to 95% in patients with ≥5 macules. Additionally, a higher number of CALMs correlated with a greater prevalence of plexiform neurofibromas (p < 0.001). Conclusions: Our findings suggest that a higher number of CALMs may indicate a more severe form of NF1, with an increased risk of plexiform neurofibromas. These results emphasize the importance of a comprehensive evaluation of patients with CALMs, especially in case of multiple lesions, aiming at implementing early NF1 diagnosis, follow-up strategies, and overall patient management.Keywords
Funding Information
- “MNESYS”—A multiscale integrated approach to the study of the nervous system in health and disease (PNRR-MUR-M4C2 PE0000006)
This publication has 30 references indexed in Scilit:
- Novel causative variants in Legius syndrome: SPRED1 Genotype spectrum expansionAmerican Journal of Medical Genetics Part A, 2024
- Surgical revascularization as a procedure to prevent neurological complications in children with moyamoya syndrome associated with neurofibromatosis I: a single institution case seriesChild's Nervous System, 2024
- Spatial coefficient of variation applied to arterial spin labeling MRI may contribute to predict surgical revascularization outcomes in pediatric moyamoya vasculopathyNeuroradiology, 2020
- Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844–848The American Journal of Human Genetics, 2018
- Predicting neurofibromatosis type 1 risk among children with isolated café-au-lait maculesJournal of the American Academy of Dermatology, 2017
- Emerging genotype–phenotype relationships in patients with large NF1 deletionsHuman Genetics, 2017
- Nevus anemicus in neurofibromatosis type 1: A potential new diagnostic criterionJournal of the American Academy of Dermatology, 2013
- Phenotypic variability among café-au-lait macules in neurofibromatosis type 1Journal of the American Academy of Dermatology, 2010
- Clinical and Mutational Spectrum of Neurofibromatosis Type 1–like SyndromeJAMA, 2009
- Predictive Value of Café au Lait Macules at Initial Consultation in the Diagnosis of Neurofibromatosis Type 1Archives of Dermatology, 2009